bendamustine hydrochloride has been researched along with Autoimmune Lymphoproliferative Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casado, F; de la Fuente, A; de la Rubia, J; Debén, G; Delgado, J; Echeveste, A; Grande, C; Lahuerta, JJ; Loscertales, J; Mateos, MV; Olave, MT; Osorio, S; Peña, A; Peñalver, FJ; Pérez Ceballos, E; Salar, A; Sastre, JL | 1 |
1 other study(ies) available for bendamustine hydrochloride and Autoimmune Lymphoproliferative Syndrome
| Article | Year |
|---|---|
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Lymphoproliferative Syndrome; Bendamustine Hydrochloride; Consensus Development Conferences as Topic; Disease Management; Humans; Multiple Myeloma; Practice Guidelines as Topic | 2016 |